Toni Schuh will serve as the new CEO of Arcturus Bioscience, the company said this week. Schuh recently stepped down as CEO of Sequenom. Arcturus also said that Schuh will be elected to its board of directors.
Schuh previously held positions at Helm and Fisions Pharmaceuticals. He holds a PhD in medicinal chemistry from the University of Bonn.